BlackThorn Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
October 21, 2016
Vertical
Biopharmaceuticals
Funding URL
View Funding Page

Company Info
Company Description
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments. BlackThorn is building a robust pipeline of first- and best-in-class treatments, and is redefining the industry approach to drug discovery and development through its INFORMâ„¢ platform, which links brain physiology and its relationship to behavior.
Market
Neurobehavioral disorders
Location
South San Francisco, California, USA
Coinvestors
Alexandria Real Estate Equities, Altitude Life Science Ventures, ARCH Venture Partners, Johnson & Johnson Innovation, Mercury Fund

Links
Back to Home Back to Biopharmaceuticals Deals View Funding Announcement